XML 26 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Adjustments to reconcile net (loss) income to net cash used in operating activities:        
Interest earned on marketable securities held in Trust Account $ (187,000) $ (75,000) $ (180,000)  
Increase (Decrease) in Operating Capital [Abstract]        
Prepaid expenses 1,041,000 (1,306,000) (2,592,000) $ (1,840,000)
Accounts payable and accrued expenses (2,772,000) 1,108,000 5,246,000 3,175,000
Net cash used in operating activities (41,196,000) (24,003,000) (32,313,000) (22,697,000)
Cash Flows from Investing Activities:        
Net cash used in investing activities (1,421,000) (1,514,000) (1,786,000) (2,258,000)
Cash Flows from Financing Activities:        
Net cash provided by financing activities 54,586,000 7,554,000 13,462,000 50,768,000
Increase (decrease) in cash, cash equivalents and restricted cash 11,969,000 (17,963,000) (20,637,000) 25,813,000
Cash, cash equivalents and restricted cash, beginning of period 9,664,000 30,301,000 30,301,000 4,488,000
Cash, cash equivalents and restricted cash, end of period 21,633,000 12,338,000 9,664,000 30,301,000
MedTech Acquisition Corp        
Net Cash Provided by (Used in) Operating Activities [Abstract]        
Net (loss) income     5,539,079 4,767,283
Adjustments to reconcile net (loss) income to net cash used in operating activities:        
Change in fair value of warrant liabilities     (5,837,332) (7,744,000)
Interest earned on marketable securities held in Trust Account     (3,018,726) (63,997)
Increase (Decrease) in Operating Capital [Abstract]        
Prepaid expenses     118,671 348,200
Income taxes payable     27,854  
Due to stockholders     48,135  
Accounts payable and accrued expenses     385,325 954,400
Net cash used in operating activities     (2,736,994) (1,738,114)
Cash Flows from Investing Activities:        
Investment of cash into Trust Account     (78,136)  
Cash withdrawn from Trust Account to pay franchise and income taxes     905,000 60,000
Cash withdrawn from Trust Account in connection with redemptions     232,371,273  
Net cash used in investing activities     233,198,137 60,000
Cash Flows from Financing Activities:        
Proceeds from promissory note     39,068  
Proceeds from promissory note - related party     400,000 544,000
Proceeds from convertible promissory note - related party     1,341,000  
Proceeds from extension note     82,741  
Redemptions of common stock     (232,371,273)  
Net cash provided by financing activities     (230,508,464) 544,000
Increase (decrease) in cash, cash equivalents and restricted cash     (47,321) (1,134,114)
Cash, cash equivalents and restricted cash, beginning of period $ 153,563 $ 200,884 200,884 1,334,998
Cash, cash equivalents and restricted cash, end of period     153,563 $ 200,884
Supplemental disclosure of cash flow information:        
Cash paid for income taxes     $ 543,000